Company

VIAN Therapeutics

Biotechnology Research San Francisco, California, United States 5 employees

Employees: 5

www.viantx.com LinkedIn

VIAN Therapeutics Overview

Headquarters: San Francisco, California, United States
Website: www.viantx.com
Industry: Biotechnology Research
Employees: 5
Founded: 2023
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

angiogenesis peptides vasopermeability diabetic retinopathy diabetic macular edema AMD macular degeneration oncology angiogenesis inhibitors antiangiogenic eye drop

About VIAN Therapeutics

VIAN Therapeutics is a visionary virtual pharma startup at the forefront of combating microvascular retinal diseases. Focused on conditions like diabetic retinopathy and age-related macular degeneration, we're pioneering a novel solution: VIAN-c4551, a groundbreaking cyclic peptide drug delivered via convenient eyedrop administration. By swiftly stabilizing retinal blood vessels, our non-invasive approach aims to halt vision deterioration earlier than traditional methods (e.g., intraocular injections). With millions affected, VIAN Therapeutics aims to redefine ocular care, offering hope for clearer sight and a brighter future of retinal health.

VIAN Therapeutics Contact Details

People in AeroLeads: 4

VIAN Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jp Robles	Vian Therapeutics CEO - Improving Antiangiogenic Therapy in Convenience and Efficacy	San Francisco, California, United States	View
Prem Patel	Doctor of Pharmacy Candidate (Pharmd) Class of 2025	Los Angeles Metropolitan Area, United States	View
Philipp N. Sander, Phd	Investor @ Indiebio/sosv - Chembio Phd from Scripps Research - Are You Building a Startup in Human or Planetary Health? Let's Chat!	San Francisco Bay Area, United States	View
Qianying Zuo	Ph.d. in Biomedical and Molecular Nutrition	Princeton, New Jersey, United States	View